JP2006518331A5 - - Google Patents

Download PDF

Info

Publication number: JP2006518331A5
Authority: JP; Japan
Prior art keywords: core; protein; polynucleotide; hcv; vaccine
Prior art date: 2003-11-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP2004552615A

Other languages

English (en)

Japanese (ja)

Other versions

JP2006518331A (ja

Filing date

2003-11-13

Publication date

2006-09-21

2002-11-15 Priority claimed from GBGB0226722.7A external-priority patent/GB0226722D0/en

2003-11-13 Application filed filed Critical

2006-08-10 Publication of JP2006518331A publication Critical patent/JP2006518331A/ja

2006-09-21 Publication of JP2006518331A5 publication Critical patent/JP2006518331A5/ja

Status Pending legal-status Critical Current

Links

JP2004552615A 2002-11-15 2003-11-13 ワクチン Pending JP2006518331A (ja)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0226722.7A GB0226722D0 (en)	2002-11-15	2002-11-15	Vaccine
PCT/EP2003/012793 WO2004046175A1 (en)	2002-11-15	2003-11-13	Vaccine

Publications (2)

Publication Number	Publication Date
JP2006518331A JP2006518331A (ja)	2006-08-10
JP2006518331A5 true JP2006518331A5 (2)	2006-09-21

Family

ID=9947928

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
JP2004552615A Pending JP2006518331A (ja)	2002-11-15	2003-11-13	ワクチン
JP2004552621A Pending JP2006524181A (ja)	2002-11-15	2003-11-13	ワクチン

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
JP2004552621A Pending JP2006524181A (ja)	2002-11-15	2003-11-13	ワクチン

Country Status (21)

Country	Link
US (4)	US20060135451A1 (2)
EP (2)	EP1560845A1 (2)
JP (2)	JP2006518331A (2)
KR (2)	KR20050085010A (2)
CN (2)	CN1738833A (2)
AR (1)	AR041964A1 (2)
AU (2)	AU2003288084A1 (2)
BR (2)	BR0316244A (2)
CA (2)	CA2504654A1 (2)
CO (1)	CO5700833A2 (2)
GB (1)	GB0226722D0 (2)
IS (2)	IS7831A (2)
MA (2)	MA27700A1 (2)
MX (2)	MXPA05005202A (2)
NO (2)	NO20052136L (2)
NZ (2)	NZ539998A (2)
PL (2)	PL376882A1 (2)
RU (2)	RU2363492C2 (2)
TW (1)	TW200502246A (2)
WO (2)	WO2004046176A1 (2)
ZA (2)	ZA200503802B (2)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7022830B2 (en) *	2000-08-17	2006-04-04	Tripep Ab	Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
GB0226722D0 (en) *	2002-11-15	2002-12-24	Glaxo Group Ltd	Vaccine
US7439042B2 (en)	2002-12-16	2008-10-21	Globeimmune, Inc.	Yeast-based therapeutic for chronic hepatitis C infection
EP2460533A3 (en) *	2004-10-18	2014-01-08	Globeimmune, Inc.	Yeast-based therapeutic for chronic hepatitis C infection
US8178086B2 (en) *	2006-01-04	2012-05-15	Novartis Vaccines And Diagnostics, Inc.	Activation of HCV specific T cells
MX2008011361A (es) *	2006-03-09	2008-09-15	Transgene Sa	Proteina de fusion no-estructural del virus de hepatitis c.
CA2657955A1 (en) *	2006-07-27	2008-08-07	Ligocyte Pharmaceuticals, Inc.	Chimeric virus-like particles
EP2044198A4 (en)	2006-07-27	2010-09-08	Ligocyte Pharmaceuticals Inc	CHIMERIC INFLUENZA VIRUS TYPE PARTICLES
KR100759106B1 (ko) *	2007-02-14	2007-09-19	이화여자대학교 산학협력단	초미세 전기기계 시스템 미러에서 미러 판을 정전 구동부와 결합하는 방법
US8071561B2 (en)	2007-08-16	2011-12-06	Chrontech Pharma Ab	Immunogen platform
RU2370776C2 (ru) *	2007-11-08	2009-10-20	Общество с ограниченной ответственностью "Диагностические Центры "Алкор Био"	Набор антигенов для раздельного выявления антител к структурным и неструктурным белкам вируса гепатита с
US9758794B2 (en)	2008-04-22	2017-09-12	Rutgers, The State University Of New Jersey	HCV E2 construct compositions and methods
CA2722423A1 (en) *	2008-04-22	2009-10-29	Rutgers, The State University	Hcv e2 construct compositions and methods
WO2010011870A2 (en) *	2008-07-24	2010-01-28	Anza Therapeutics, Inc.	Compositions and methods for the treatment of hepatitis c
WO2010033841A1 (en)	2008-09-19	2010-03-25	Globeimmune, Inc.	Immunotherapy for chronic hepatitis c virus infection
CN101748151B (zh) *	2008-12-19	2012-10-17	深圳市源兴生物医药科技有限公司	一种重组人丙肝病毒抗原腺病毒载体及其应用
JP2010168288A (ja) *	2009-01-20	2010-08-05	Yokohama City Univ	最適化した抗原遺伝子の使用によるウイルスワクチンの免疫原性の増強
US8920812B2 (en)	2009-11-03	2014-12-30	Takeda Vaccines, Inc.	Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS
CN102233137B (zh) *	2010-04-30	2013-02-20	北京凯因科技股份有限公司	一种用于治疗乙型肝炎的重组质粒dna疫苗组合物
JP2016513115A (ja) *	2013-02-21	2016-05-12	チルドレンズホスピタルオブイースタンオンタリオリサーチインスティチュートインコーポレイテッド	ワクチン組成物
CN119504957B (zh) *	2025-01-16	2025-04-25	中山大学	一种佐剂及其在制备疫苗中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4945050A (en) *	1984-11-13	1990-07-31	Cornell Research Foundation, Inc.	Method for transporting substances into living cells and tissues and apparatus therefor
JPH02500880A (ja) *	1987-11-18	1990-03-29	カイロン　コーポレイション	Ｎａｎｂｖの診断用薬およびワクチン
CA2070952A1 (en) *	1991-06-11	1992-12-12	Makoto Seki	Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
US6297048B1 (en) *	1992-02-04	2001-10-02	Chiron Corporation	Hepatitis therapeutics
HUT77870A (hu) *	1994-10-05	1998-09-28	Apollon, Inc.	Hepatitiszvírus elleni vakcinák
AU5924396A (en) *	1995-05-22	1996-12-11	Bionova Corporation	Compositions and methods for the diagnosis of, and vaccinati on against, hepatitis c virus (hcv)
WO1997047358A1 (en) *	1996-06-11	1997-12-18	Merck & Co., Inc.	Synthetic hepatitis c genes
US7052696B2 (en) *	1998-07-10	2006-05-30	The United States Of America As Represented By The Department Of Health And Human Services	Antigenic epitopes and mosaic polypeptides of hepatitis C virus proteins
CA2379235A1 (en) *	1999-07-09	2001-01-18	The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services, Centers For Disease Co	Antigenic epitopes and mosaic polypeptides of hepatitis c virus proteins
AU1236801A (en) *	1999-10-27	2001-05-08	Chiron Corporation	Activation of hcv-specific t cells
WO2001038360A2 (en) *	1999-11-24	2001-05-31	Chiron Corporation	Novel hcv non-structural polypeptide
FI116851B (fi) *	2001-05-03	2006-03-15	Fit Biotech Oyj Plc	Ilmentämisvektori, sen käyttöjä ja menetelmä sen valmistamiseksi sekä sitä sisältäviä tuotteita
DE10143490C2 (de) *	2001-09-05	2003-12-11	Gsf Forschungszentrum Umwelt	Rekombinantes MVA mit der Fähigkeit zur Expression von HCV Struktur-Antigenen
GB0226722D0 (en) *	2002-11-15	2002-12-24	Glaxo Group Ltd	Vaccine

2002
- 2002-11-15 GB GBGB0226722.7A patent/GB0226722D0/en not_active Ceased
2003
- 2003-11-13 BR BR0316244-3A patent/BR0316244A/pt not_active IP Right Cessation
- 2003-11-13 WO PCT/EP2003/012830 patent/WO2004046176A1/en not_active Ceased
- 2003-11-13 KR KR1020057008794A patent/KR20050085010A/ko not_active Ceased
- 2003-11-13 EP EP03779952A patent/EP1560845A1/en not_active Withdrawn
- 2003-11-13 CA CA002504654A patent/CA2504654A1/en not_active Abandoned
- 2003-11-13 US US10/534,774 patent/US20060135451A1/en not_active Abandoned
- 2003-11-13 WO PCT/EP2003/012793 patent/WO2004046175A1/en not_active Ceased
- 2003-11-13 CA CA002504715A patent/CA2504715A1/en not_active Abandoned
- 2003-11-13 US US10/535,047 patent/US20060246090A1/en not_active Abandoned
- 2003-11-13 PL PL376882A patent/PL376882A1/pl not_active Application Discontinuation
- 2003-11-13 AR ARP030104193A patent/AR041964A1/es unknown
- 2003-11-13 MX MXPA05005202A patent/MXPA05005202A/es active IP Right Grant
- 2003-11-13 CN CNA200380108865XA patent/CN1738833A/zh active Pending
- 2003-11-13 RU RU2005113691/13A patent/RU2363492C2/ru not_active IP Right Cessation
- 2003-11-13 NZ NZ539998A patent/NZ539998A/en unknown
- 2003-11-13 BR BR0316291-5A patent/BR0316291A/pt not_active IP Right Cessation
- 2003-11-13 KR KR1020057008793A patent/KR20050085009A/ko not_active Ceased
- 2003-11-13 JP JP2004552615A patent/JP2006518331A/ja active Pending
- 2003-11-13 PL PL376967A patent/PL376967A1/pl not_active Application Discontinuation
- 2003-11-13 EP EP03779938A patent/EP1560844A1/en not_active Withdrawn
- 2003-11-13 CN CNA2003801088698A patent/CN1738834A/zh active Pending
- 2003-11-13 AU AU2003288084A patent/AU2003288084A1/en not_active Abandoned
- 2003-11-13 MX MXPA05005203A patent/MXPA05005203A/es not_active Application Discontinuation
- 2003-11-13 NZ NZ539999A patent/NZ539999A/en unknown
- 2003-11-13 JP JP2004552621A patent/JP2006524181A/ja active Pending
- 2003-11-13 RU RU2005113692/13A patent/RU2323744C2/ru not_active IP Right Cessation
- 2003-11-13 TW TW092131802A patent/TW200502246A/zh unknown
- 2003-11-13 AU AU2003288072A patent/AU2003288072A1/en not_active Abandoned
2005
- 2005-04-28 IS IS7831A patent/IS7831A/is unknown
- 2005-04-28 IS IS7830A patent/IS7830A/is unknown
- 2005-05-02 NO NO20052136A patent/NO20052136L/no not_active Application Discontinuation
- 2005-05-02 NO NO20052149A patent/NO20052149L/no not_active Application Discontinuation
- 2005-05-11 ZA ZA200503802A patent/ZA200503802B/en unknown
- 2005-05-11 ZA ZA200503803A patent/ZA200503803B/en unknown
- 2005-05-16 MA MA28285A patent/MA27700A1/fr unknown
- 2005-05-16 MA MA28284A patent/MA27699A1/fr unknown
- 2005-06-10 CO CO05056623A patent/CO5700833A2/es not_active Application Discontinuation
2008
- 2008-07-17 US US12/174,715 patent/US20090104231A1/en not_active Abandoned
2009
- 2009-05-26 US US12/471,772 patent/US20090232847A1/en not_active Abandoned

Publication	Publication Date	Title
JP2006518331A5 (2)	2006-09-21
RU2363492C2 (ru)	2009-08-10	Вакцина
Collett et al.	1991	Bovine viral diarrhea virus genomic organization
Becher et al.	1998	Complete genomic sequence of border disease virus, a pestivirus from sheep
CA2389206A1 (en)	2001-05-03	Activation of hcv-specific t cells
JP2006149406A5 (2)	2007-06-14
JP4504464B2 (ja)	2010-07-14	キメラフラビウイルスワクチン
JP2006501825A5 (2)	2006-11-16
JP2005538932A5 (2)	2006-03-16
JP2008516610A5 (2)	2008-12-04
FI107610B (fi)	2001-09-14	HCV-fuusioproteiini
JP2004532023A5 (2)	2008-01-10
JP2005505286A5 (2)	2006-01-05
BR9905902A (pt)	2000-12-12	Clone de cdna infeccioso do vìrus da sìndrome reprodutiva e respiratória de porcino norte-americana (prrs) e seus usos
JP2003530307A5 (2)	2006-12-07
JP2019525744A5 (2)	2020-07-27
JP2006506097A5 (2)	2007-01-11
EP2275565A3 (en)	2011-04-27	Nucleic acids encoding TGEV and PRRSV sequences for improved expression of PRRSV sequences
JP2004531242A5 (2)	2005-06-23
JP2005532064A5 (2)	2006-08-10
Hirowatari et al.	1993	Two proteinase activities in HCV polypeptide expressed in insect cells using baculovirus vector
CA2505942A1 (en)	2004-06-03	West nile virus vaccine
CA2390082A1 (en)	2001-05-31	Novel hcv non-structural polypeptide
RU2005102484A (ru)	2006-01-20	Слитые белки hcv c модифицированными доменами ns3
JP2004501650A5 (2)	2008-07-31